Re: Question on valuing shares from time of spinoff

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Question on valuing shares from time of spinoff

in response to

Question on valuing shares from time of spinoff

bfw

posted on Sep 13, 2018 12:03AM

It really doesn't matter what your brokerage values it at, it what you valued it at at the time of the split.